This case study explores how a pre-clinical stage company is leveraging Watershed's bioinformatics solution to develop a novel approach to small molecule drug discovery.

The company aims to use their unique target identification platform discover new, more effective medicines for complex diseases.

    Thank you! Your submission has been received!
    Oops! Something went wrong while submitting the form.